Publication | Open Access
Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial
388
Citations
23
References
2015
Year
Autoimmune DiseaseClinical TrialsInflammatory MarkerClinical DermatologyTofacitinib VersusPharmacotherapyNon-inferiority TrialDermatologyMedicinePhase 3
| Year | Citations | |
|---|---|---|
Page 1
Page 1